169 related articles for article (PubMed ID: 11169830)
1. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging.
Chung JJ; Semelka RC; Martin DR
J Magn Reson Imaging; 2001 Feb; 13(2):242-8. PubMed ID: 11169830
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
3. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
4. Exophytic benign tumors of the liver: appearance on MRI.
Bader TR; Braga L; Semelka RC
Magn Reson Imaging; 2001 Jun; 19(5):623-8. PubMed ID: 11672619
[TBL] [Abstract][Full Text] [Related]
5. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: Utility of dynamic, contrast enhancement and single-shot T2-weighted sequences.
Becker-Weidman D; Kalb B; Mittal PK; Harri PA; Arif-Tiwari H; Farris AB; Chen Z; Sungjin K; Martin DR
Eur J Radiol; 2015 Nov; 84(11):2045-51. PubMed ID: 26233268
[TBL] [Abstract][Full Text] [Related]
7. Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions.
Rodacki K; Ramalho M; Dale BM; Battisti S; de Campos RO; Giardino A; Semelka RC
AJR Am J Roentgenol; 2014 Jul; 203(1):99-106. PubMed ID: 24951201
[TBL] [Abstract][Full Text] [Related]
8. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
9. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
10. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies.
Krestin GP; Steinbrich W; Friedmann G
Radiology; 1989 Jun; 171(3):675-80. PubMed ID: 2717737
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT.
Krestin GP; Freidmann G; Fishbach R; Neufang KF; Allolio B
J Comput Assist Tomogr; 1991; 15(1):104-10. PubMed ID: 1987177
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Maycher B; Madden TP; Kroeker MA
J Magn Reson Imaging; 1993; 3(2):337-43. PubMed ID: 8448395
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced dynamic MRI of adrenal masses: classification of characteristic enhancement patterns.
Ichikawa T; Ohtomo K; Uchiyama G; Fujimoto H; Nasu K
Clin Radiol; 1995 May; 50(5):295-300. PubMed ID: 7743717
[TBL] [Abstract][Full Text] [Related]
14. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
15. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
Marcos HB; Semelka RC
J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
[TBL] [Abstract][Full Text] [Related]
16. Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization--preliminary findings.
Semelka RC; Worawattanakul S; Mauro MA; Bernard SA; Cance WG
J Magn Reson Imaging; 1998; 8(1):48-56. PubMed ID: 9500260
[TBL] [Abstract][Full Text] [Related]
17. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies.
Słapa RZ; Jakubowski W; Dabrowska E; Januszewicz A; Tymińska B; Feltynowski T; Lapiński M; Fijuth J
MAGMA; 1996; 4(3-4):163-79. PubMed ID: 9220405
[TBL] [Abstract][Full Text] [Related]
20. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
